‘Swift’ Vascepa Victory Puts Hikma And Reddy’s In Pole Position

But Analyst Calls Generic Threat ‘Overstated’

 
• By Dean Rudge
  
Appeal_Gavel
Amarin has suggested that appeal action against Vascepa ANDA sponsors is not over yet • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin